PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis

被引:98
作者
Ding, HL
Wu, XF [1 ]
Gao, W
机构
[1] Third Mil Med Univ, Dept Nephrol, Southwest Hosp, Chongqing 400038, Peoples R China
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Immunol,Transplant Res Ctr, Boston, MA 02215 USA
基金
中国国家自然科学基金;
关键词
renal tubular epithelial cells; PD-L1; T cells; cytokine;
D O I
10.1016/j.clim.2005.01.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell activation is affected by both stimulatory and inhibitory co-signaling. NIHC class II-expressing renal tubular epithelial cells (TEC) can function as APC for T cells. To study the influence of inhibitory ligands oil TEC-mediated T cell activation, we examined the expression of programmed death ligand-1 (PD-L1) on human TEC line HK-2 cells, as well as in normal and diseased kidney samples. RT-PCR, FACS, and immunocytochemistry showed that PD-L1 is constitutively expressed on HK-2 cells, and is dramatically Upregulated by IFN-gamma. In situ hybridization and immunohistochemical staining revealed constitutive low expression of PD-L1 on proximal tubules at both mRNA and protein levels in normal kidneys, but much higher expression in kidneys with type IV lupus nephritis. In vitro, pretreatment of IFN-gamma-stimulated HK-2 cells with anti-PD-L1 significantly enhanced IL-2 secretion from cocultured, mitogen-activated Jurkat or human peripheral blood T cells. These results suggest that the PD-L1:PD-1 pathway negatively regulates T cell activation by TEC, and may play an inhibitory role in TEC-mediated immune activation and immunopathology in the kidney. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:184 / 191
页数:8
相关论文
共 64 条
[21]   REGULATION OF THE COSTIMULATOR B7, NOT CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX, RESTRICTS THE ABILITY OF MURINE KIDNEY TUBULE CELLS TO STIMULATE CD4(+) T-CELLS [J].
HAGERTY, DT ;
EVAVOLD, BD ;
ALLEN, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1208-1215
[22]  
HAGERTY DT, 1992, J IMMUNOL, V148, P2324
[23]   Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine [J].
He, YF ;
Zhang, GM ;
Wang, XH ;
Zhang, H ;
Yuan, Y ;
Li, D ;
Feng, ZH .
JOURNAL OF IMMUNOLOGY, 2004, 173 (08) :4919-4928
[24]   Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade [J].
Iwai, Y ;
Ishida, M ;
Tanaka, Y ;
Okazaki, T ;
Honjo, T ;
Minato, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12293-12297
[25]   PD-1 inhibits antiviral immunity at the effector phase in the liver [J].
Iwai, YH ;
Terawaki, S ;
Ikegawa, M ;
Okazaki, T ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :39-50
[26]   DIFFERING REGULATION AND FUNCTION OF ICAM-1 AND CLASS-II ANTIGENS ON RENAL TUBULAR CELLS [J].
JEVNIKAR, AM ;
WUTHRICH, RP ;
TAKEI, F ;
XU, HW ;
BRENNAN, DC ;
GLIMCHER, LH ;
RUBINKELLEY, VE .
KIDNEY INTERNATIONAL, 1990, 38 (03) :417-425
[27]   Blockade of B7-H1 suppresses intestinal inflammation the development of chronic [J].
Kanai, T ;
Totsuka, T ;
Uraushihara, K ;
Makita, S ;
Nakamura, T ;
Koganei, K ;
Fukushima, T ;
Akiba, H ;
Yagita, H ;
Okumura, K ;
Machida, T ;
Iwai, H ;
Azuma, M ;
Chen, LP ;
Watanabe, M .
JOURNAL OF IMMUNOLOGY, 2003, 171 (08) :4156-4163
[28]   The roles of the new negative T cell costimulatory pathways in regulating autoimmunity [J].
Khoury, SJ ;
Sayegh, MH .
IMMUNITY, 2004, 20 (05) :529-538
[29]   Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice [J].
Kinoshita, K ;
Tesch, G ;
Schwarting, A ;
Maron, R ;
Sharpe, AH ;
Kelley, VR .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :6046-6056
[30]   PD-L2 is a second ligand for PD-I and inhibits T cell activation [J].
Latchman, Y ;
Wood, CR ;
Chernova, T ;
Chaudhary, D ;
Borde, M ;
Chernova, I ;
Iwai, Y ;
Long, AJ ;
Brown, JA ;
Nunes, R ;
Greenfield, EA ;
Bourque, K ;
Boussiotis, VA ;
Carter, LL ;
Carreno, BM ;
Malenkovich, N ;
Nishimura, H ;
Okazaki, T ;
Honjo, T ;
Sharpe, AH ;
Freeman, GJ .
NATURE IMMUNOLOGY, 2001, 2 (03) :261-268